Predictive value of the APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device.

ABSTRACT:

Background

The APACHE II score assesses patient prognosis in intensive care units. Different disease entities are predictable by using a specific factor called Diagnostic Category Weight (DCW). We aimed to validate the prognostic value of the APACHE II score in patients treated with a percutaneous left ventricular assist device because of refractory cardiogenic shock (CS).

Methods

From the Dresden Impella Registry, we analyzed 180 patients receiving an Impella CP®. The main outcome was the observed intrahospital mortality ( S^(thosp) ), which was compared to the predicted mortality estimated by the APACHE II score.

Results

The APACHE II score, which was 33.5 ± 0.6, significantly overestimated intrahospital mortality ( S^(thosp) 54.4 ± 3.7% vs. APACHE II 74.6 ± 1.6%; p

SUBMITTER: Mierke J 

PROVIDER: S-EPMC8971639 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature